Showing results (141-150 of 168) with videos related to

Sort By:
Pageof 17
Atherosclerosis|February 6, 2007
Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosisM W Lorenz, C Stephan, A Harmjanz, et al.
The Journal of Infectious Diseases|August 7, 1999
A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapyM Hirsch, R Steigbigel, S Staszewski, et al.
AIDS (London, England)|November 4, 2000
The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral loadV Miller, C A Sabin, A N Phillips, et al.
AIDS (London, England)|March 9, 2000
HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapyV Miller, M Ait-Khaled, C Stone, et al.
AIDS (London, England)|May 1, 1995
A dose comparison study of didanosine in patients with very advanced HIV infection who are intolerant to or clinically deteriorate on zidovudine. German ddI Trial GroupH Jablonowski, K Arasteh, S Staszewski, et al.
The Journal of Infection|July 6, 2010
Intensification of a failing regimen with zidovudine may cause sustained virologic suppression in the presence of resensitising mutations including K65RC Stephan, B Dauer, M Bickel, et al.
AIDS (London, England)|December 2, 1998
A dose-ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment-naive subjectsS Staszewski, C Katlama, T Harrer, et al.
The Journal of Infectious Diseases|November 6, 2004
Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study groupA Mocroft, B Ledergerber, J P Viard, et al.
HIV Medicine|September 1, 2007
A standardized, comprehensive magnetic resonance imaging protocol for rapid and precise quantification of HIV-1-associated lipodystrophyM Bickel, J Eisen, C Stephan, et al.
Leukemia|July 25, 2008
c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemiaE D Lagadinou, P G Ziros, O A Tsopra, et al.
Pageof 17